Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Marriott International Inc (MAR) vs Revvity Inc (RVTY) Price & Performance

Marriott International Inc Trade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

Marriott International Inc vs Revvity Inc — how do they compare? Marriott International Inc trades at $349.51 (market cap $91.14B), while Revvity Inc trades at $117.6 (market cap $12.91B). The key difference: Marriott International Inc is far larger — about 7.1× Revvity Inc's market cap, and Marriott International Inc pays the higher dividend (0.84%). Which is the better fit depends on your goals.

MARRVTY
Market Cap
$91.14B$12.91B
Sector
Consumer CyclicalTechnology
52-Week High
$402.54$117.75
52-Week Low
$259.04$82.26
Enterprise Value
$108.45B$15.23B
Dividend Yield
0.84%0.24%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Marriott International Inc

Marriott International (MAR) trades at $355.34, up 1.98% today, with a bearish technical signal despite recent earnings beats. The stock shows strong profitability with a 9.62% net income margin and robust cash flow from operations of $3.21B in 2025, though its valuation remains elevated with a P/E of 36.18. Recent news highlights dividend declarations and AI-driven booking tools, while rising debt levels and Middle East weakness present challenges.

The outlook is mixed; analyst consensus leans bullish with a $387.31 price target, but high valuation and increasing debt-to-asset ratio (58.83% in 2025) cap upside potential. Key risks include regional volatility and competitive pressures, while fee revenue growth and a record pipeline offer opportunities for long-term investors.

Revvity Inc

RVTY trades at $116.10, up 0.07% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The company reported Q2 2026 EPS of $1.41, surpassing the $1.21 estimate, and raised its full-year outlook due to robust diagnostics demand. Revenue remains steady around $2.9 billion, with a net income margin of 8.16%. Analyst consensus is a Buy with a $120.50 price target, and recent news highlights product launches like the SuperFlex prenatal system and high-throughput TB testing platform.

The outlook for RVTY is positive, supported by earnings momentum and strategic innovations, but investors face risks from high valuation multiples and competitive pressures in the healthcare sector. The stock's proximity to its consensus target suggests limited near-term upside, requiring careful monitoring of execution against raised guidance.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Marriott International Inc

Marriott International Inc. of Maryland is a worldwide operator and franchisor of hotels. The Company franchises lodging facilities and vacation timesharing resorts under various brand names. Marriott also provides services to home and condominium owner associations for projects associated with several of its brands.

Read more on MAR

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY